CA2201025A1 - Medicament - Google Patents

Medicament

Info

Publication number: CA2201025A1
Authority: CA; Canada
Prior art keywords: medicine; sharks; cartilage; flesh; spinal fluid
Prior art date: 1997-03-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2201025

Other languages

English (en)

Inventor

Larry Wayne Brundritt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-26

Filing date

1997-03-26

Publication date

1998-09-26

1997-03-26 Application filed by Individual filed Critical Individual

1997-03-26 Priority to CA 2201025 priority Critical patent/CA2201025A1/fr

1998-09-26 Publication of CA2201025A1 publication Critical patent/CA2201025A1/fr

Status Abandoned legal-status Critical Current

Links

239000003814 drug Substances 0.000 title claims abstract description 24
229940079593 drug Drugs 0.000 title description 2
241000251730 Chondrichthyes Species 0.000 claims abstract description 13
208000005176 Hepatitis C Diseases 0.000 claims abstract description 4
241000700605 Viruses Species 0.000 claims abstract description 4
210000000845 cartilage Anatomy 0.000 claims description 17
239000012530 fluid Substances 0.000 claims description 7
241001466453 Laminaria Species 0.000 claims description 4
241000512259 Ascophyllum nodosum Species 0.000 claims description 3
241001416164 Squalidae Species 0.000 claims description 3
210000000577 adipose tissue Anatomy 0.000 claims description 3
230000000694 effects Effects 0.000 claims description 3
208000024891 symptom Diseases 0.000 claims description 2
241000567769 Isurus oxyrinchus Species 0.000 claims 1
241000251125 Prionace glauca Species 0.000 claims 1
241000251778 Squalus acanthias Species 0.000 claims 1
201000010099 disease Diseases 0.000 claims 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
239000003053 toxin Substances 0.000 claims 1
231100000765 toxin Toxicity 0.000 claims 1
108700012359 toxins Proteins 0.000 claims 1
241000251468 Actinopterygii Species 0.000 abstract description 3
241000894006 Bacteria Species 0.000 abstract description 3
206010017533 Fungal infection Diseases 0.000 abstract description 3
208000031888 Mycoses Diseases 0.000 abstract description 3
238000011282 treatment Methods 0.000 abstract description 3
239000000203 mixture Substances 0.000 abstract description 2
241000271566 Aves Species 0.000 abstract 1
206010008874 Chronic Fatigue Syndrome Diseases 0.000 abstract 1
241000282412 Homo Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 abstract 1
238000004321 preservation Methods 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
238000000034 method Methods 0.000 description 4
241000251161 Carcharhinidae Species 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
235000019688 fish Nutrition 0.000 description 2
239000003921 oil Substances 0.000 description 2
239000013535 sea water Substances 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
208000019901 Anxiety disease Diseases 0.000 description 1
208000006820 Arthralgia Diseases 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229920001287 Chondroitin sulfate Polymers 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
206010016807 Fluid retention Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
206010022998 Irritability Diseases 0.000 description 1
241000251223 Lamninae Species 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
241000782099 Squaliformes Species 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
239000005864 Sulphur Substances 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
230000036506 anxiety Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229940059329 chondroitin sulfate Drugs 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
230000004438 eyesight Effects 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000000227 grinding Methods 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
-1 manganease Chemical compound 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
231100001078 no known side-effect Toxicity 0.000 description 1
239000006187 pill Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
206010037844 rash Diseases 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000011573 trace mineral Substances 0.000 description 1
235000013619 trace mineral Nutrition 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019156 vitamin B Nutrition 0.000 description 1
239000011720 vitamin B Substances 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
235000019168 vitamin K Nutrition 0.000 description 1
239000011712 vitamin K Substances 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Natural Medicines & Medicinal Plants (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Alternative & Traditional Medicine (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Marine Sciences & Fisheries (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA 2201025 1997-03-26 1997-03-26 Medicament Abandoned CA2201025A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA 2201025 CA2201025A1 (fr)	1997-03-26	1997-03-26	Medicament

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2201025 CA2201025A1 (fr)	1997-03-26	1997-03-26	Medicament

Publications (1)

Publication Number	Publication Date
CA2201025A1 true CA2201025A1 (fr)	1998-09-26

Family

ID=4160255

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2201025 Abandoned CA2201025A1 (fr)	1997-03-26	1997-03-26	Medicament

Country Status (1)

Country	Link
CA (1)	CA2201025A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002049654A1 (fr) *	2000-12-20	2002-06-27	Industrial Research Limited	Extrait de viande de requin
EP1270009A1 (fr) *	2001-06-26	2003-01-02	Houzawa, Hiromi	Agent antiviral contenant une combinaison de sels de calcium d'origine organique (poissons et coquilles) et minérale
WO2003068249A1 (fr) *	2002-02-15	2003-08-21	Ocean Nutrition Canada Limited	Extrait de cartilage de requin et utilisation de celui-ci a des fins d'immunomodulation
US6627229B2 (en)	2000-02-18	2003-09-30	Hiromi Houzawa	Antiviral agent and method of producing the same
WO2006009478A1 (fr) *	2004-07-22	2006-01-26	University Of Otago	Compositions contre le cancer contenant un extrait de chair de requin et un extrait de champignon

1997
- 1997-03-26 CA CA 2201025 patent/CA2201025A1/fr not_active Abandoned

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6627229B2 (en)	2000-02-18	2003-09-30	Hiromi Houzawa	Antiviral agent and method of producing the same
WO2002049654A1 (fr) *	2000-12-20	2002-06-27	Industrial Research Limited	Extrait de viande de requin
EP1270009A1 (fr) *	2001-06-26	2003-01-02	Houzawa, Hiromi	Agent antiviral contenant une combinaison de sels de calcium d'origine organique (poissons et coquilles) et minérale
WO2003068249A1 (fr) *	2002-02-15	2003-08-21	Ocean Nutrition Canada Limited	Extrait de cartilage de requin et utilisation de celui-ci a des fins d'immunomodulation
US7504115B2 (en)	2002-02-15	2009-03-17	Ocean Nutrition Canada Limited	Shark cartilage extracts and use thereof for immunomodulation
WO2006009478A1 (fr) *	2004-07-22	2006-01-26	University Of Otago	Compositions contre le cancer contenant un extrait de chair de requin et un extrait de champignon

Legal Events

Date	Code	Title	Description
2000-03-27	FZDE	Dead

Publication	Publication Date	Title
CN101795685A (zh)	2010-08-04	羟脯氨酸组合物及其用途
WO2010037213A1 (fr)	2010-04-08	Compositions comprenant des extraits de plante et leur utilisation pour traiter l'inflammation
LT5657B (lt)	2010-06-28	Melsvadumblio spirulina platensis konservavimas natūraliu bičių medumi
JP2010535493A (ja)	2010-11-25	動物給餌用生成品及び動物用生成品の製造工程
Ranasinghe et al.	2022	Nutritional value and potential applications of jellyfish
CA2336602C (fr)	2010-11-02	Friandise therapeutique pour animaux de compagnie
KR20170051126A (ko)	2017-05-11	통증 경감용 고약
ATE114471T1 (de)	1994-12-15	Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.
RU2111680C1 (ru)	1998-05-27	Пищевое вещество "мос ленкин" биозащитного действия
Mgasa	1987	Bovine pododermatitis aseptica diffusa (laminitis) aetiology, pathogenesis, treatment and control
Papi et al.	2025	The fascinating history of wound healing through fine arts
AU771808B2 (en)	2004-04-01	Methods and compositions for the support, regeneration and repair of connective tissues
US20070155666A1 (en)	2007-07-05	Canine and equine collagen joint health supplement
CN110201098B (zh)	2021-04-13	一种治疗畜禽痢疾的复方蜂胶组合物及其制备方法与应用
KR102255146B1 (ko)	2021-05-21	아밀로이드β 섬유 분해제, 아밀로이드β의 섬유화에 기인하는 질환의 치료약·예방약 및 치료용·예방용 식품조성물
EP1834647A1 (fr)	2007-09-19	Supplément pour la santé d'articulations de collagène chez les chiens et les chevaux
JP2003171289A (ja)	2003-06-17	鎮痛用医薬組成物
RU2438360C2 (ru)	2012-01-10	Природная композиция биологически активных веществ из панцирных отходов креветки определенного цикла развития, получение, использование (варианты)
Moberg	1939	On widespread subcutaneous calcifications in the connective tissue of the leg
Marketos et al.	2008	The Healing Art in the Iliad
NL1020729C2 (nl)	2003-12-02	Calciumbevattende samenstelling, werkwijze voor het bereiden daarvan, en farmaceutisch preparaat op basis van de samenstelling.
CN1168471C (zh)	2004-09-29	治疗复发性口疮、湿疹的药物
CN1895444A (zh)	2007-01-17	烫伤冲剂
ES2750632T3 (es)	2020-03-26	Utilización de un extracto particular de propóleo para luchar contra los efectos secundarios de quimioterapias
JP3267962B1 (ja)	2002-03-25	牡蠣肉エキス及びその製造方法